Doctor profile · Federal record

Dr. Lauren Snitzer, M.D.

Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Sugar Land, TX

  • NPI 1225391543
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 14 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1327 Lake Pointe Pkwy Ste 416
Sugar Land, TX 774783499
(281) 494-0050
fax (281) 494-0075
Mailing address
5310 Harvest Hill RD Ste 290
Dallas, TX 752305826

Credentials & registration

NPPES · NUCC
NPI registered
June 2012 — 14 yrs on file
Profile last updated
July 21, 2022
Year of graduation
2012 — 14 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (2)
Texas #R2017 · Missouri #2012018188

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1225391543. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,733
Distinct HCPCS
10
Medicare allowed
$208,166
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,395 201 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 792 513 $87
11102 Biopsy of related skin growth, first growth 382 300 $91
17000 Destruction of precancer skin growth, 1 growth 361 254 $48
11103 Biopsy of related skin growth, each additional growth 192 110 $49
17110 Destruction of skin growth, 1-14 growths 155 120 $106
99212 Established patient office or other outpatient visit, 10-19 minutes 108 99 $55
99203 New patient office or other outpatient visit, 30-44 minutes 107 107 $108
99214 Established patient office or other outpatient visit, 30-39 minutes 60 46 $123
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 46 42 $160

In context: peer comparison

Among 8 peers in this city , average services per provider: 187. This provider delivers 20× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,557
Transactions
214
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 40 $883.70
ABBVIE INC. 37 $751.81
Arcutis Biotherapeutics, Inc. 18 $323.53
Lilly USA, LLC 18 $294.26
PFIZER INC. 13 $272.89
GENZYME CORPORATION 7 $257.61
Regeneron Healthcare Solutions, Inc. 8 $256.77
SUN PHARMACEUTICAL INDUSTRIES INC. 11 $248.09
UCB, Inc. 5 $247.33
Dermavant Sciences, Inc. 18 $196.87
Amgen Inc. 18 $188.14
Ortho Dermatologics, a division of Bausch Health US, LLC 7 $130.22
Novartis Pharmaceuticals Corporation 4 $116.99
Incyte Corporation 5 $108.02
E.R. Squibb & Sons, L.L.C. 5 $104.79

By nature of payment

Food and Beverage
$4,477
Education
$80

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
834
Patients
495
Total drug cost
$25,712
Drug Type Claims Patients Total cost
Ketoconazole Generic 172 98 $2,782
Triamcinolone Acetonide Generic 131 98 $1,597
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 108 73 $4,104
Clobetasol Propionate Generic 79 46 $6,263
Doxycycline Hyclate Generic 73 45 $3,578
Hydrocortisone Generic 71 57 $458
Mupirocin Generic 47 39 $415
Clindamycin Phosphate Generic 28 14 $1,476
Valacyclovir (Valacyclovir Hcl) Brand 26 14 $857
Fluocinonide Generic 19 0 $1,023

Frequently asked questions

Auto-generated from federal data
What is Dr. Lauren Snitzer's medical specialty?
Dr. Lauren Snitzer practices Dermatology Physician in Sugar Land, TX.
Where does Dr. Lauren Snitzer practice?
Dr. Lauren Snitzer practices at 1327 Lake Pointe Pkwy Ste 416, Sugar Land, TX 774783499. Office phone: 2814940050.
What is Dr. Lauren Snitzer's NPI?
Dr. Lauren Snitzer's National Provider Identifier (NPI) is 1225391543, issued by NPPES.
Does Dr. Lauren Snitzer accept Medicare assignment?
Yes. Dr. Lauren Snitzer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lauren Snitzer commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.